Тhe current standards of chemotherapy of childhood TB recommend a specific set of drugs for treatment initiation, an optimal consequence of drug replacement, and treatment duration; however, they cannot recommend the most appropriate alternative for a specific patient in a special situation. The articlescribes two clinical cases illustrating individualized approaches to chemotherapy of childhood TB, which cannot be treated using standard chemotherapy regimens due to various reasons; these approaches have resulted in favourable outcomes of the disease. The individualized approach to treatment of a patient co-infected with HIV/TB excluded rifampicin despite preserved sensitivity to first- and second-line drugs and involved continued antiretroviral therapy (ART) without correction. A patient with advanced sputum negative pulmonary TB without risk of developing MDR received additional second-line drugs and a prolonged intensive phase of treatment up to 8 months. In both cases effective treatment results were achieved without surgical interventions.
Read full abstract